BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• Press Releases

  Ōmcare Debuts “Phygital” Home Health Platform at CES

  December 11, 2024

   · 

  3 min read
• Press Releases

  Xaira Therapeutics Announces the Appointment of Dr. Paulo Fontoura as Chief Medical Officer and Dr. Hetu Kamisetty as Chief Technology Officer

  December 11, 2024

   · 

  5 min read
• Press Releases

  Agendia Demonstrates MammaPrint® Utility in Predicting Chemotherapy Benefit Over 5 Years in Patients with HR+HER2- Early Breast Cancer at SABCS 2024

  December 11, 2024

   · 

  4 min read
• Press Releases

  Genesis Therapeutics Expands Leadership Team with Appointments of Chief Scientific Officer, SVP of Engineering, and Board Chairman

  December 11, 2024

   · 

  4 min read
• Press Releases

  SamanTree Medical Highlights Research Showing 67% Reduction in Reoperation Rates for Breast-Conserving Surgery at the 2024 SABCS

  December 11, 2024

   · 

  3 min read
• 

  Immunology and inflammation

  Acelyrin Terminates Izokibep After Failed Phase IIb/III Uveitis Data

  The discontinuation caps off a turbulent development path for izokibep, which in September 2023 produced disappointing results from Phase IIb/III study in hidradenitis suppurativa that was found to have had dosing errors.

  December 11, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Policy

  Pushback Against IRA’s Controversial ‘Pill Penalty’ Faces Stiff Budgetary Headwinds

  The EPIC Act has been proposed with bipartisan and industry support to give small molecule drugs the same protection against price negotiation as biologics, but concerns over how to balance the federal budget could prevent a short-term fix to the IRA.

  December 11, 2024

   · 

  5 min read

   · 

  Ben Hargreaves
• Press Releases

  AbbVie Completes Acquisition of Aliada Therapeutics

  December 11, 2024

   · 

  2 min read
• Press Releases

  Truvian Health Appoints Dr. Tina Nova to its Board of Directors

  December 11, 2024

   · 

  2 min read
• Press Releases

  Jackson Pharmacy Professionals Unveils Brand Refresh and New Identity as “Jackson PharmacyPros”

  December 11, 2024

   · 

  2 min read